News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Histotripsy 2.0 available for liver and breast cancer clinical trials in HK
05 Dec 2024
byChristina Lau
Asia’s first histotripsy 2.0 system, introduced at the Chinese University Hong Kong (CUHK) recently, will be used in clinical trials to treat liver cancer patients from early 2025. The novel focal therapy will also be evaluated in patients with early-stage breast cancer.
05 Dec 2024

Fezolinetant eases symptoms in menopausal women unfit for hormone therapy
04 Dec 2024
byStephen Padilla
Use of fezolinetant demonstrates efficacy and good tolerability in the treatment of moderate-to-severe vasomotor symptoms associated with menopause in women who are deemed unsuitable for hormone therapy, reports a study.
04 Dec 2024

Pooled analysis ASSUREs seladelpar role in PBC
04 Dec 2024
byAudrey Abella
Results of the phase III ASSURE study support seladelpar – a novel first-in-class delpar (selective peroxisome proliferator-activated receptor delta agonist) – for the treatment of primary biliary cholangitis (PBC).
04 Dec 2024






